These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27020403)

  • 21. Systemic sclerosis: New evidence re-enforces the role of B cells.
    Sakkas LI; Bogdanos DP
    Autoimmun Rev; 2016 Feb; 15(2):155-61. PubMed ID: 26497107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of B cells in systemic sclerosis.
    Fukasawa T; Yoshizaki-Ogawa A; Sato S; Yoshizaki A
    J Dermatol; 2024 Jul; 51(7):904-913. PubMed ID: 38321641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.
    Mavropoulos A; Simopoulou T; Varna A; Liaskos C; Katsiari CG; Bogdanos DP; Sakkas LI
    Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.
    Chizzolini C
    Ann Med; 2007; 39(1):42-53. PubMed ID: 17364450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunopathological disturbances in systemic sclerosis].
    Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
    Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenesis of systemic scleroderma: immunological aspects].
    Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L
    Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [B cell abnormalities and autoantibody production in systemic sclerosis].
    Sato S
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):73-84. PubMed ID: 16651705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B Lymphocyte signaling established by the CD19/CD22 loop regulates autoimmunity in the tight-skin mouse.
    Asano N; Fujimoto M; Yazawa N; Shirasawa S; Hasegawa M; Okochi H; Tamaki K; Tedder TF; Sato S
    Am J Pathol; 2004 Aug; 165(2):641-50. PubMed ID: 15277237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A modified model of graft-versus-host-induced systemic sclerosis (scleroderma) exhibits all major aspects of the human disease.
    Ruzek MC; Jha S; Ledbetter S; Richards SM; Garman RD
    Arthritis Rheum; 2004 Apr; 50(4):1319-31. PubMed ID: 15077316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated B cell function and disease pathogenesis in systemic sclerosis.
    Beesley CF; Goldman NR; Taher TE; Denton CP; Abraham DJ; Mageed RA; Ong VH
    Front Immunol; 2022; 13():999008. PubMed ID: 36726987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis.
    Noda S; Asano Y; Nishimura S; Taniguchi T; Fujiu K; Manabe I; Nakamura K; Yamashita T; Saigusa R; Akamata K; Takahashi T; Ichimura Y; Toyama T; Tsuruta D; Trojanowska M; Nagai R; Sato S
    Nat Commun; 2014 Dec; 5():5797. PubMed ID: 25504335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B lymphocytes and systemic sclerosis.
    Fujimoto M; Sato S
    Curr Opin Rheumatol; 2005 Nov; 17(6):746-51. PubMed ID: 16224253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
    Usategui A; del Rey MJ; Pablos JL
    Expert Rev Clin Immunol; 2011 Jul; 7(4):491-8. PubMed ID: 21790292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrosis and immune dysregulation in systemic sclerosis.
    Chizzolini C; Brembilla NC; Montanari E; Truchetet ME
    Autoimmun Rev; 2011 Mar; 10(5):276-81. PubMed ID: 20863906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological basis of systemic sclerosis.
    Zuber JP; Spertini F
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
    Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
    Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.